IL37 and psoriasis: Results of the study confirmed the superior activity of naringin/sericin combination compared with each compound alone on down-regulation of the pro-inflammatory cytokines including IL-6, IL-12p40, IL-23 and TNF-α related to early inflammation mechanisms of psoriasis pathogenesis.